The global Interventional Cardiology Devices Market was valued at USD 22.23 billion in 2024 and is projected to reach USD 37.29 billion by 2032, growing at a CAGR of 6.68%. The U.S. dominates the market with USD 5.69 billion in 2024, expected to climb to USD 9.38 billion by 2032 due to demand for minimally invasive procedures and technological innovations.

The market is witnessing rapid adoption of precision-guided interventions, expanding cardiac catheterization labs in Asia-Pacific and Latin America, and rising healthcare investments. Major players include Boston Scientific, Medtronic, and Abbott Laboratories.

In 2024, the coronary stents segment held a revenue share of 35.32%, with percutaneous coronary intervention (PCI) dominating the industry at over 55.76%. The drug-eluting segment led with a revenue market share of 60.52%, while the hospitals & clinics segment accounted for 60.22% of the market.

The Asia Pacific region is projected to witness the fastest CAGR of 7.07% due to a rising prevalence of cardiovascular diseases, a geriatric population, and increasing incidence of diabetes and obesity. North America accounted for the highest revenue share of 38.80% in 2024.

Boston Scientific launched the SYNERGY XD drug-eluting stent in Europe, while Medtronic introduced the IN.PACT Admiral drug-coated balloon in the U.S. and expanded robotic-assisted PCI systems across Europe and Latin America for precise cardiovascular interventions. The Interventional Cardiology Devices Market is projected to reach USD 37.29 billion by 2032 with a CAGR of 6.68% from 2025 to 2032. Key segments include coronary stents, structural heart devices, and catheters. Regional analysis covers North America, Europe, Asia Pacific, Middle East & Africa, and Latin America. Access the complete report for more details.

S&S Insider is a leading market research and consulting agency providing clients with current, accurate market data and consumer insights. With a focus on adapting to changing circumstances, we use various techniques like surveys and focus groups to gather information globally. For more information or customized research, contact us at [email protected].

Read more at GlobeNewswire: Interventional Cardiology Devices Market to Hit USD 37.29